This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Can New Age Beverages (NBEV) Beat Q2 Earnings Estimates?
by Zacks Equity Research
New Age Beverages (NBEV) benefits from strong brand portfolio and efforts to expand national distribution in the United States. These and other initiatives should bolster its second-quarter results.
Buyouts & Price/Mix to Aid Flowers Foods' (FLO) Q2 Earnings
by Zacks Equity Research
Flowers Foods (FLO) Q2 results are likely to gain from solid buyouts. The company is also poised to benefit from Project Centennial and efficient price/mix amid rising costs.
Top Ranked Growth Stocks to Buy for August 6th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, August 6th
Why Monster Beverage (MNST) is Likely to Beat on Q2 Earnings
by Zacks Equity Research
Monster Beverage's (MNST) top and bottom lines in second-quarter 2019 are likely to witness positive trends, owing to strength in the energy drinks business, particularly the Monster Brand.
Is a Disappointment in Store for Nu Skin (NUS) Q2 Earnings?
by Zacks Equity Research
Nu Skin's (NUS) Q2 performance is likely to be hurt by the government campaign in Mainland China to inspect offerings of direct selling industries and health products.
Weak Volumes Likely to Hurt Dean Foods (DF) in Q2 Earnings
by Zacks Equity Research
Dean Foods (DF) grapples with cost inflation and soft volumes, which are expected to dent Q2 performance.
Will Chicken Segment Drive Tyson Foods' (TSN) Q3 Earnings?
by Zacks Equity Research
Tyson Foods (TSN) is likely to gain from its Chicken and Beef segments in third-quarter fiscal 2019, given the rising demand for protein. Input costs in the Prepared Foods category are expected to rise.
Avon (AVP) Q2 Earnings & Sales Beat Estimates, Stock Up
by Zacks Equity Research
Avon's (AVP) sales and earnings in second-quarter 2019 gain from progress on the Open Up Avon strategy. Its focus on pricing and productivity initiatives drives adjusted operating margin growth.
Estee Lauder (EL) Stock Moves -0.78%: What You Should Know
by Zacks Equity Research
In the latest trading session, Estee Lauder (EL) closed at $182.76, marking a -0.78% move from the previous day.
Clorox (CLX) Q4 Earnings Top Estimates, Soft View Hurts Stock
by Zacks Equity Research
Clorox (CLX) reports mixed fourth-quarter fiscal 2019 results. Lower taxes and gross margin expansion aid its earnings while lower volume and unfavorable currency hurt sales.
Zacks.com featured highlights include: Ensign, Ciena, KB Home, Est??e Lauder and Rush Enterprises
by Zacks Equity Research
Zacks.com featured highlights include: Ensign, Ciena, KB Home, Est??e Lauder and Rush Enterprises
Why Newell's (NWL) Q2 Earnings Are Likely to Decline Y/Y
by Zacks Equity Research
Lower core sales and adverse foreign exchange are likely to hurt Newell's (NWL) second-quarter 2019 results.
Procter & Gamble (PG) Stock Up on Q4 Earnings & Sales Beat
by Zacks Equity Research
Procter & Gamble (PG) posts robust fourth-quarter fiscal 2019 results. Also, the company provided upbeat guidance for fiscal 2020.
5 Stocks That Boast of Impressive Interest Coverage Ratio
by Sumit Singh
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.
Can Cost and Tariff Woes Mar Clorox's (CLX) Earnings in Q4?
by Zacks Equity Research
Clorox's (CLX) fourth-quarter fiscal 2019 results are likely to bear impacts of higher commodity costs, adverse currency, increased manufacturing and logistics expenses, and tariffs.
Check Out Avon's (AVP) Probability to Beat Earnings in Q2
by Zacks Equity Research
Avon's (AVP) Open Up strategy is likely to drive second-quarter 2019 results. However, its soft Representatives growth and adverse currency remain deterrents.
Why Archer Daniels' (ADM) Q2 Earnings Are Likely to Fall Y/Y
by Zacks Equity Research
Archer Daniels' (ADM) soft Carbohydrate Solutions unit due to impacts of adverse weather conditions, lower ethanol volumes and issues at Decatur complex is likely to hurt second-quarter 2019 results.
Are You Looking for a Top Momentum Pick? Why Estee Lauder (EL) is a Great Choice
by Zacks Equity Research
Does Estee Lauder (EL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Factors Likely to Influence Sprouts Farmers (SFM) Q2 Earnings
by Zacks Equity Research
Sprouts Farmers (SFM) is focused on product innovation, customer experience and technology. These are likely to favorably impact Q2 net sales. However, any deleverage in SG&A and direct store expenses cannot be ignored.
Will Cost Woes Hurt B&G Foods (BGS) This Earnings Season?
by Zacks Equity Research
Input costs related to freight and warehousing are likely to dent B&G Foods' (BGS) Q2 performance. Also, the Pirate Brands' divestiture is likely to dent sales.
Things You Need to Know Before Molson Coors' (TAP) Q2 Earnings
by Zacks Equity Research
Molson Coors' (TAP) second-quarter 2019 results are likely to remain bleak, thanks to soft volume, adverse currency and cost inflation. Tough beer industry is also likely to hurt results.
Why Procter & Gamble (PG) is Poised to Beat on Q4 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) fourth-quarter fiscal 2019 results are set to gain from ongoing productivity efforts, robust organic growth, higher shipment volume and favorable price/mix.
Colgate (CL) Q2 Earnings & Sales Miss Estimates, Decline Y/Y
by Zacks Equity Research
Colgate (CL) posts lower-than-expected second-quarter 2019 results. Foreign currency translations remain a major headwind in the quarter.
Kellogg's (K) Q2 Earnings Likely to be Hurt by Rising Costs
by Zacks Equity Research
Kellogg's (K) Q2 performance is likely to gain from strong brands. However, rising costs and currency headwinds are concerns.
Estee Lauder (EL) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Estee Lauder (EL) closed at $189.53, marking a +0.04% move from the previous day.